Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simpler, faster ECG match the gold standard?

NCT ID NCT07732283

Diagnosis Sponsor: Clinique Bizet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This trial tests whether a 4-electrode tablet-based ECG (DigitalCardio) can record heart activity as quickly and clearly as the standard 10-electrode ECG. About 50 cardiology patients will undergo both methods in random order. Researchers will measure recording time and compare trace quality, including automated measurements and missing leads.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the 4-electrode ECG proves faster and equally reliable, it could simplify heart monitoring and reduce patient discomfort.
What could go wrong
This is a small, early-stage comparison study. The new device may not match the diagnostic accuracy of the standard ECG, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Hospitalized Cardiology Patients: * Age minimum 18 years * Hospitalized for an acute or chronic cardiac condition (e.g., heart failure, acute coronary syndrome, arrhythmia, valvular heart disease, etc.) * Ability to give informed consent * Hemodynamic stability permitting the performance of an ECG without clinical risk Cardiology Outpatients: * Age minimum of 18 years * Follow-up for a known cardiac condition or suspected cardiovascular disease * No contraindications to performing an ECG * Informed consent obtained Exclusion Criteria: * Minor patient (\< 18 years of age) * Adult subject under legal protection, under temporary guardianship, curatorship, or tutelage * Patient refusing to participate in the study * Presence of an implantable cardiac device (e.g., pacemaker, defibrillator) that may interfere with ECG measurements * Severe skin condition preventing the placement of electrodes * Physical or cognitive inability to follow the study protocol * Current pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 4-electrode tablet-based electrocardiogram (ECG) system are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart conduction disease long QT syndrome myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

4-electrode tablet-based electrocardiogram (ECG) system Atrial or ventricular arrhythmias Electrical activity of the heart Intracardiac conduction abnormalities Myocardial ischemia QT interval prolongation Tandard 12-lead (10-electrode) ecg device Ventricular hypertrophy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Benkessou

    NOT_YET_RECRUITING

    Paris, 75016, France

  • Bizet Clinic

    RECRUITING

    Paris, 75016, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.